Los Angeles Times

FDA approves gene therapy to fix mutations that can lead to blindness

In a decision that accelerates a new era for gene therapy, the Food and Drug Administration on Tuesday approved a DNA-altering medication that can reverse an inherited form of progressive blindness.

The FDA's blessing makes Luxturna, a treatment for retinal dystrophy caused by a specific genetic mutation, the first gene therapy cleared for use in the U.S. to treat a genetic disease other than cancer.

Tuesday's announcement marks the third time in five months that the

You're reading a preview, sign up to read more.

More from Los Angeles Times

Los Angeles Times1 min read
Angels Broadcaster Mark Langston Taken To Hospital After A Medical Emergency
HOUSTON - Angels radio broadcaster Mark Langston was transported to a Houston hospital after suffering a medical emergency at Minute Maid Park on Friday evening. Langston was alert and undergoing testing, the Angels announced. There was no further in
Los Angeles Times3 min read
Kershaw Rocked Then Rolls
LOS ANGELES_If getting ejected for complaining about a strike call from the dugout and storming onto the field to berate an umpire were to inspire the Los Angeles Dodgers like it seemed to Friday night, then manager Dave Roberts might want to try it
Los Angeles Times5 min read
Michael Hiltzik: Can Trump Legally Revoke California's Clean Air Waiver? Probably Not
President Donald Trump's latest attempt to stick his thumb in California's eye - the revocation of the state's treasured authority to set its own auto emissions rules - rests on very shaky legal ground, experts say. At the very least, the move to rev